Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-TIM3 chimeric antigen receptor-natural killer cells from engineered induced pluripotent stem cells effectively target acute myeloid leukemia cells ; volume:23 ; number:1 ; day:27 ; month:11 ; year:2023 ; pages:1-16 ; date:12.2023
Cancer cell international ; 23, Heft 1 (27.11.2023), 1-16, 12.2023
- Creator
-
Klaihmon, Phatchanat
Luanpitpong, Sudjit
Kang, Xing
Issaragrisil, Surapol
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-023-03153-9
- URN
-
urn:nbn:de:101:1-2024021413432230670049
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Klaihmon, Phatchanat
- Luanpitpong, Sudjit
- Kang, Xing
- Issaragrisil, Surapol
- SpringerLink (Online service)
Other Objects (12)
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Chimeric Antigen Receptor T-Cell Therapy
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Chimeric Antigen Receptor T-Cell Therapy
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Developing new chimeric antigen receptor (CAR)-engineered natural killer cells targeting ovarian cancer stem cells
T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy